Cargando…
Chemical Classes Presenting Novel Antituberculosis Agents Currently in Different Phases of Drug Development: A 2010–2020 Review
Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), is a curable airborne disease currently treated using a drug regimen consisting of four drugs. Global TB control has been a persistent challenge for many decades due to the emergence of drug-resistant Mtb strains. The duration and comple...
Autores principales: | Angula, Klaudia T., Legoabe, Lesetja J., Beteck, Richard M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152995/ https://www.ncbi.nlm.nih.gov/pubmed/34068171 http://dx.doi.org/10.3390/ph14050461 |
Ejemplares similares
-
Quinolone-3-amidoalkanol:
A New Class of Potent and
Broad-Spectrum Antimicrobial Agent
por: Dube, Phelelisiwe S., et al.
Publicado: (2023) -
Quinolone: a versatile therapeutic compound class
por: Dube, Phelelisiwe S., et al.
Publicado: (2022) -
Exploration of 4-aminopyrrolo[2,3-d]pyrimidine as antitubercular agents
por: Jesumoroti, Omobolanle Janet, et al.
Publicado: (2022) -
An Update on Development of Small-Molecule Plasmodial Kinase Inhibitors
por: Moolman, Chantalle, et al.
Publicado: (2020) -
Anti-Trypanosomal and Antimalarial Properties of Tetralone Derivatives and Structurally Related Benzocycloalkanones
por: Beteck, Richard M., et al.
Publicado: (2019)